LI
QTTB icon

Leap Investments’s Q32 Bio QTTB Stock Holding History

Leap Investments’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$169K Buy
+617
New +$164K 0.11% 319

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Leap Investments's QTTB Position: Q2 2020 in Review

Leap Investments opened a new position in Q32 Bio (QTTB) in Q2 2020: 617 shares worth $169K. The stake represents 0.11% of the portfolio and ranks #319 among its holdings.

102 funds tracked by Wall St. Rank hold QTTB as of Q2 2020.

  • Leap Investments held 617 shares of Q32 Bio worth $169K as of Q2 2020.
  • Q32 Bio was a new Leap Investments position in Q2 2020.
  • Q32 Bio made up 0.11% of Leap Investments's portfolio in Q2 2020, its #319 holding.
  • 102 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.